Carregant...
Beta blockers and angiotensin converting enzyme inhibitors’ purported benefit on breast cancer survival may be explained by aspirin use
Preclinical and epidemiologic evidence supports a possible role for beta-adrenergic blocking drugs (beta-blockers), and angiotensin converting enzyme inhibitors (ACEIs) in promoting survival after breast cancer. However, these drugs are often used concurrently with aspirin, and there is a growing bo...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3683855/ https://ncbi.nlm.nih.gov/pubmed/23649190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-013-2553-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|